Anna Springer
Impact in
-
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in ⓘ
-
- Paraoxonase enzyme and polymorphisms 1
-
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- T Junginger (1 shared paper)Joachim Seifert (1 shared paper)Tobias Madl (5 shared papers)Alexander Mahnert (1 shared paper)Christoph Högenauer (1 shared paper)Florian Ph. S. Fischmeister (1 shared paper)Ivan A. Berg (1 shared paper)Christina Kumpitsch (1 shared paper)
- Journals
- iScience (2 papers)International Journal of Molecular Sciences (1 paper)Atherosclerosis (1 paper)International Journal of Colorectal Disease (1 paper)Microbiome (1 paper)
- Partner nations
- GermanyAustriaSwitzerland
In The Last Decade
Anna Springer
6 papers receiving 111 citations
Peers
Comparison fields: 5 of 52
- Hepatology 30
- Oncology 22
- Molecular Biology 53
- Gastroenterology 4
- Surgery 31
Countries citing papers authored by Anna Springer
This map shows the geographic impact of Anna Springer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Springer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Springer more than expected).
Fields of papers citing papers by Anna Springer
This network shows the impact of papers produced by Anna Springer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Springer. The network helps show where Anna Springer may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Springer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 47 | |
| 2 | 2005 | 35 | |
| 3 | 2021 | 15 | |
| 4 | 2021 | 9 | |
| 5 | 2021 | 5 | |
| 6 | 2021 | 4 |
About Anna Springer
Anna Springer is a scholar working on Clinical Biochemistry, Cancer Research, Hepatology, Physiology and Pharmacology, having authored 6 papers that have together received 115 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper), Paraoxonase enzyme and polymorphisms (1 paper), Apelin-related biomedical research (1 paper), Metabolism, Diabetes, and Cancer (1 paper) and Cardiovascular Health and Disease Prevention (1 paper). The work is most often cited by research in Hepatology (30 citations), Oncology (22 citations), Molecular Biology (53 citations), Gastroenterology (4 citations) and Surgery (31 citations). Anna Springer has collaborated with scholars based in Germany, Austria and Switzerland. Frequent co-authors include T Junginger, Joachim Seifert, Tobias Madl, Alexander Mahnert, Christoph Högenauer, Florian Ph. S. Fischmeister, Ivan A. Berg, Christina Kumpitsch, Christine Moissl‐Eichinger and Sonja Lackner. Their work appears in journals such as iScience, International Journal of Molecular Sciences, Atherosclerosis, International Journal of Colorectal Disease and Microbiome.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.